This article was originally published in The Gray Sheet
Nets $19.6 mil. from secondary offering, completed on July 27, of 1 mil. shares (plus 150,000 in underwriter overallotments) at $18 per share. The Waltham, Massachusetts-based firm had estimated $21.2 mil. in net proceeds in a filing with the Securities and Exchange Commission ("The Gray Sheet" July 5, p. 21).
You may also be interested in...
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.